Relationship between Personality Traits and Endogenous Analgesia: The Role of Harm Avoidance

Pain Practice

Volumn 16, Issue 1, 2016, Pages 38-45

  Nahman Averbuch, Hadas ^a   Yarnitsky, David ^a,b   Sprecher, Elliot ^a   Granovsky, Yelena ^a,b   Granot, Michal ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Anxiety; Conditioned pain modulation; Harm avoidance; Pain catastrophizing; Tridimensional Personality Questionnaire

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONDITIONED PAIN MODULATION; CONDITIONING; ENDOGENOUS ANALGESIA; FEMALE; HARM AVOIDANCE; HUMAN; HUMAN EXPERIMENT; MALE; MIDDLE AGED; NOCICEPTION; NORMAL HUMAN; NOVELTY SEEKING; PAIN ASSESSMENT; PAIN CATASTROPHIZING; PAIN CATASTROPHIZING SCALE; PERSONALITY; PERSONALITY ASSESSMENT; PSYCHOPHYSICS; REWARD DEPENDENCE; STATE TRAIT ANXIETY INVENTORY; TEMPORAL SUMMATION; TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; WATER IMMERSION; ANALGESIA; CATASTROPHIZING; HEAT; NEUROPSYCHOLOGICAL TEST; PAIN; PAIN MEASUREMENT; PERSONALITY TEST; PSYCHOLOGY; SEXUAL DEVELOPMENT;

ANALGESIA; ANXIETY; CATASTROPHIZATION; CONDITIONING (PSYCHOLOGY); FEMALE; HEALTHY VOLUNTEERS; HOT TEMPERATURE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN; PAIN MEASUREMENT; PERSONALITY; PERSONALITY TESTS; SEX CHARACTERISTICS;

EID: 84955205429     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12256     Document Type: Article

References (54)

1. Benarroch EE. Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology. 2008;71:217-221.
2. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355-474.
3. Baba Y, Kohase H, Oono Y, Fujii-Abe K, Arendt-Nielsen L. Effects of dexmedetomidine on conditioned pain modulation in humans. Eur J Pain. 2012;16:1137-1147.
4. Lindstedt F, Berrebi J, Greayer E, et al. Conditioned pain modulation is associated with common polymorphisms in the serotonin transporter gene. PLoS ONE. 2011;6:18252.
5. Treister R, Pud D, Eisenberg E. The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans. Neurosci Lett. 2013;548:115-119.
6. Grosen K, Vase L, Pilegaard HK, Pfeiffer-Jensen M, Drewes AM. Conditioned pain modulation and situational pain catastrophizing as preoperative predictors of pain following chest wall surgery: a prospective observational cohort study. PLoS ONE. 2014;9:e90185.
7. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138:22-28.
8. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153:1193-1198.
9. Granot M, Weissman-Fogel I, Crispel Y, et al. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: do conditioning stimulus painfulness, gender and personality variables matter? Pain. 2008;136:142-149.
10. Piché M, Bouin M, Arsenault M, Poitras P, Rainville P. Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience. 2011;10:166-175.
11. Cormier S, Piché M, Rainville P. Expectations modulate heterotopic noxious counter-stimulation analgesia. J Pain. 2013;14:114-125.
12. Johannesson U, de Boussard CN, Brodda Jansen G, Bohm-Starke N. Evidence of diffuse noxious inhibitory controls (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia. Pain. 2007;2:31-39.
13. Edwards RR, Grace E, Peterson S, Klick B, Haythornthwaite JA, Smith MT. Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur J Pain. 2009;13:1043-1047.
14. van Laarhoven AI, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PC, Evers AW. Heterotopic pruritic conditioning and itch-analogous to DNIC in pain? Pain. 2010;149:332-337.
15. Nir RR, Yarnitsky D, Honigman L, Granot M. Cognitive manipulation targeted at decreasing the conditioning pain perception reduces the efficacy of conditioned pain modulation. Pain. 2012;153:170-176.
16. Rezaii T, Hirschberg AL, Carlström K, Ernberg M. The influence of menstrual phases on pain modulation in healthy women. J Pain. 2012;13:646-655.
17. Nahman-Averbuch H, Granovsky Y, Coghill RC, Yarnitsky D, Sprecher E, Weissman-Fogel I. Waning of "conditioned pain modulation": a novel expression of subtle pronociception in migraine. Headache. 2013;53:1104-1115.
18. Tsao JC, Seidman LC, Evans S, Lung KC, Zeltzer LK, Naliboff BD. Conditioned pain modulation in children and adolescents: effects of sex and age. J Pain. 2013;14:558-567.
19. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573-588.
20. Eisenberg E, Cohen D, Lawental E, Pud D. Personality traits and sensitivity to pain in male chronic opioid addicts. J Opioid Manag. 2007;3:225-230.
21. Pud D, Eisenberg E, Sprecher E, Rogowski Z, Yarnitsky D. The tridimensional personality theory and pain: harm avoidance and reward dependence traits correlate with pain perception in healthy volunteers. Eur J Pain. 2004;8:31-38.
22. Pud D, Yarnitsky D, Sprecher E, Rogowski Z, Adler R, Eisenberg E. Can personality traits and gender predict the response to morphine? An experimental cold pain study. Eur J Pain. 2006;10:103-112.
23. d'Agostino VC, Francia E, Licursi V, Cerbo R. Clinical and personality features of allodynic migraine. Neurol Sci. 2010;31:159-161.
24. Granot M. Personality traits associated with perception of noxious stimuli in women with vulvar vestibulitis syndrome. J Pain. 2005;6:168-173.
25. Ziv M, Tomer R, Defrin R, Hendler T. Individual sensitivity to pain expectancy is related to differential activation of the hippocampus and amygdala. Hum Brain Mapp. 2010;31:326-338.
26. Zohar AH, Lev-Ari L, Benjamin J, Ebsteinc R, Lichtenbergc P, Osherd Y. The psychometric properties of the Hebrew version of Cloninger's TPQ. Pers Indiv Differ. 2001;30:118-128.
27. Spielberger CD, Gorsuch RL, Lushene R. The State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1969.
28. Teichman Y, Malineck F. Manual for the Hebrew State-Trait Anxiety Inventory. Tel-Aviv, Israel: Tel-Aviv University Press; 1978.
29. Barnes LLB, Harp D, Jung WS. Reliability generalization of scores on the Spielberger State-Trait Anxiety Inventory. Educ Psychol Measur. 2002;62:603-618.
30. Sullivan MJL, Bishop S, Pivic J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7:524-532.
31. Granot M, Goldstein Ferber S. Prediction of post-operative pain intensity by assessment of pain catastrophizing scale and anxiety. Clin J Pain. 2005;21:439-445.
32. Granot M, Granovsky Y, Sprecher E, Nir RR, Yarnitsky D. Contact heat-evoked temporal summation: tonic versus repetitive-phasic stimulation. Pain. 2006;122:295-305.
33. Nahman-Averbuch H, Yarnitsky D, Granovsky G, Gerber E, Dagul P, Granot M. The effect of stimulation parameters on 'conditioned pain modulation' response. Scand J Pain. 2013;4:10-14.
34. Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011;41:1073-1093.
35. Yarnitsky D, Granot M, Granovsky Y. Pain modulation profile and pain therapy: between pro- and antinociception. Pain. 2014;155:663-665.
36. Gardini S, Cloninger CR, Venneri A. Individual differences in personality traits reflect structural variance in specific brain regions. Brain Res Bull. 2009;79:265-270.
37. Piche M, Arsenault M, Rainville P. Cerebral and cerebrospinal processes underlying counterirritation analgesia. J Neurosci. 2009;29:14236-14246.
38. Sprenger C, Bingel U, Buchel C. Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation. Pain. 2011;152:428-439.
39. Treister R, Pud D, Ebstein RP, et al. Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation. J Pain. 2011;12:875-883.
40. Potvin S, Larouche A, Normand E, et al. No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain. 2010;14:742-746.
41. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 2000;25:479-496.
42. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol. 1999;51:77-81.
43. Jokela M, Lehtimaki T, Keltikangas-Jarvinen L. The serotonin receptor 2A gene moderates the influence of parental socioeconomic status on adulthood harm avoidance. Behav Genet. 2007;37:567-574.
44. Melke J, Westberg L, Nilsson S, et al. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry. 2003;60:1017-1023.
45. Blairy S, Massat I, Staner L, et al. 5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet. 2000;96:360-364.
46. Hillert L, Jovanovic H, Ahs F, Savic I. Women with multiple chemical sensitivity have increased harm avoidance and reduced 5-HT(1A) receptor binding potential in the anterior cingulate and amygdala. PLoS ONE. 2013;8:54781.
47. Kusumi I, Suzuki K, Sasaki Y, Kameda K, Sasaki T, Koyama T. Serotonin 5-HT(2A) receptor gene polymorphism, 5-HT(2A) receptor function and personality traits in healthy subjects: a negative study. J Affect Disord. 2002;68:235-241.
48. Peirson AR, Heuchert JW, Thomala L, Berk M, Plein H, Cloninger CR. Relationship between serotonin and the temperament and character inventory. Psychiatry Res. 1999;89:29-37.
49. Allgulander C, Cloninger CR, Przybeck TR, Brandt L. Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacol Bull. 1998;34:165-166.
50. Joffe RT, Bagby RM, Levitt AJ, Regan JJ, Parker JD. The Tridimensional Personality Questionnaire in major depression. Am J Psychiatry. 1993;150:959-960.
51. Kim SJ, Kim YS, Lee HS, Kim SY, Kim CH. An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. J Neural Transm. 2006;113:877-886.
52. Suzuki A, Matsumoto Y, Oshino S, Kamata M, Goto K, Otani K. Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females. Neurosci Lett. 2008;439:52-55.
53. Nir RR, Granovsky Y, Yarnitsky D, Sprecher E, Granot M. A psychophysical study of endogenous analgesia: the role of the conditioning pain in the induction and magnitude of conditioned pain modulation. Eur J Pain. 2011;15:491-497.
54. Goodin BR, McGuire L, Allshouse M, et al. Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences. J Pain. 2009;10:180-190.